Request for Research Proposals: Imbokodo HIV Vaccine Efficacy Trial (HVTN 705/VAC89220HPX2008)

Request for Research Proposals: Imbokodo HIV Vaccine Efficacy Trial (HVTN 705/VAC89220HPX2008)

The HIV Vaccine Trials Network (HVTN), the NIH/NIAID Division of AIDS (DAIDS), and Janssen Vaccines and Prevention are pleased to welcome scientific study proposals involving specimens and/or study data from the Imbokodo (HVTN 705/VAC89220HPX2008) HIV vaccine clinical trial.
HVTN News - February 07, 2023
Coordination of COVID-19 Vaccine Clinical Trials Produces a ‘Treasure Trove’ of Data and a Model for the Future

Coordination of COVID-19 Vaccine Clinical Trials Produces a ‘Treasure Trove’ of Data and a Model for the Future

Harmonized approach and vast database of trial participants could bolster future research well beyond SARS-CoV-2
News Releases - January 23, 2023
Newly defined biomarker may accelerate clinical trials for vaccines to prevent HIV-1 infection

Newly defined biomarker may accelerate clinical trials for vaccines to prevent HIV-1 infection

A study published in the Aug. 22, 2022 issue of Nature Medicine identifies a new biomarker that appears effective as a surrogate endpoint to reliably predict the ability of broadly neutralizing monoclonal antibodies to prevent acquisition of HIV-1, the most common type of the virus that causes AIDS.
News Releases - August 24, 2022
CoVPN Trial: Novavax’s Traditional COVID-19 Vaccine Correlates to Strong Antibody Response, Protection Against SARS-CoV-2

CoVPN Trial: Novavax’s Traditional COVID-19 Vaccine Correlates to Strong Antibody Response, Protection Against SARS-CoV-2

Response comparable to mRNA vaccines and if authorized, could help bolster global vaccine supplies
News Releases - June 28, 2022
HVTN Launches First of Its Kind Volunteer Registry

HVTN Launches First of Its Kind Volunteer Registry

Red Ribbon Registry Opens to Volunteers for HIV Vaccine Studies
HVTN News - May 18, 2022

News on HVTN

Read MORE
A promising HIV vaccine candidate gets a little help New strategy stirs a robust response from T cells tracked by McElrath lab May 24, 2023
Year in Pictures: 2022 A look back at the year through compelling images December 12, 2022
Could a 100-year-old TB vaccine help scientists find a better one? Harmless vaccine BCG is made of living bacteria; in tests might serve as a proxy for deadly tuberculosis December 12, 2022
Dr. Larry Corey receives Alexander Fleming Award Virologist honored by peers for his lifetime achievements against infectious diseases October 21, 2022